Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3776
Arcadia Biosciences
RKDA
$1.36M
| $130K | ﹤0.01% |
3,241
+1,294
| +66% | +$59.5K |
|
|
CMCM
3777
Cheetah Mobile
CMCM
$86.6M
| $129K | ﹤0.01% |
37,505
+2,160
| +6% | +$8.73K |
|
|
YJ
3778
Yunji
YJ
$6.16M
| $129K | ﹤0.01% |
3,103
-727
| -19% | -$30.6K |
|
|
SEAC
3779
DELISTED
Seachange International Inc
SEAC
| $129K | ﹤0.01% |
10,715
-8,628
| -45% | -$150K |
|
3780
Aveanna Healthcare
AVAH
$2.04B
| $128K | ﹤0.01% |
56,811
-28,973
| -34% | -$84K |
|
|
JG
3781
Aurora Mobile
JG
$33.4M
| $128K | ﹤0.01% |
6,015
+2,495
| +71% | +$50.6K |
|
3782
Moleculin Biotech
MBRX
$2.83M
| $128K | ﹤0.01% |
235
+75
| +47% | +$43.6K |
|
|
KA
3783
DELISTED
Kineta, Inc. Common Stock
KA
| $128K | ﹤0.01% |
10,073
+1,443
| +17% | +$13.9K |
|
|
LL
3784
DELISTED
LL Flooring Holdings, Inc.
LL
| $128K | ﹤0.01% |
+13,700
| New | +$167K |
|
|
UFAB
3785
DELISTED
Unique Fabricating, Inc.
UFAB
| $127K | ﹤0.01% |
93,677
+1,000
| +1% | +$1.52K |
|
|
DAO
3786
Youdao
DAO
$2.03B
| $126K | ﹤0.01% |
+25,600
| New | +$153K |
|
3787
Lantern Pharma
LTRN
$33.6M
| $126K | ﹤0.01% |
22,100
+11,400
| +107% | +$68K |
|
|
WKEY
3788
WISeKey
WKEY
$70.3M
| $126K | ﹤0.01% |
20,300
+11,000
| +118% | +$92.9K |
|
|
CYTH
3789
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
| $126K | ﹤0.01% |
63,986
-11,801
| -16% | -$28.6K |
|
|
SNCE
3790
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $126K | ﹤0.01% |
+3,140
| New | +$229K |
|
|
LMFA
3791
DELISTED
LM Funding America
LMFA
| $125K | ﹤0.01% |
1,023
+930
| +1,000% | +$235K |
|
3792
Protalix BioTherapeutics
PLX
$191M
| $125K | ﹤0.01% |
114,800
+102,900
| +865% | +$120K |
|
|
MCOM
3793
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
| $124K | ﹤0.01% |
25
+24
| +2,400% | +$260K |
|
|
ASAP
3794
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $124K | ﹤0.01% |
40,740
+21,741
| +114% | +$96.1K |
|
3795
Ardelyx
ARDX
$1.22B
| $123K | ﹤0.01% |
208,993
-1,086,600
| -84% | -$800K |
|
3796
Cibus
CBUS
$147M
| $122K | ﹤0.01% |
10,080
+9,722
| +2,716% | +$205K |
|
3797
CareCloud
CCLD
$104M
| $122K | ﹤0.01% |
+35,600
| New | +$141K |
|
|
NMTR
3798
DELISTED
9 Meters Biopharma
NMTR
| $122K | ﹤0.01% |
23,465
-88,890
| -79% | -$838K |
|
3799
Xenetic Biosciences
XBIO
$5.82M
| $121K | ﹤0.01% |
15,106
-4,035
| -21% | -$32.6K |
|
|
MYND
3800
Mynd.ai
MYND
$18M
| $120K | ﹤0.01% |
20,357
-1,214
| -6% | -$9.31K |
|
Similar funds
Renaissance Technologies's Q2 2022 Portfolio in Review
As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
- Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
- Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
- Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.